Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keiichi Torimoto

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Diabetes, Obesity & Metabolism|May 11, 2019
Addition of canagliflozin to insulin improves glycaemic control and reduces insulin dose in patients with type 2 diabetes mellitus: A randomized controlled trialKeiichi Torimoto, Yosuke Okada, Yukiko Goshima, et al.
Scientific Reports|February 17, 2022
Hypoglycemia induces vascular endothelial dysfunction in subjects with normal glucose toleranceKenichi Tanaka, Yosuke Okada, Keiichi Torimoto, et al.
Internal Medicine (Tokyo, Japan)|October 13, 2017
The Effects of Mitiglinide and Repaglinide on Postprandial Hyperglycemia in Patients Undergoing Methylprednisolone Pulse TherapyKenichi Tanaka, Yosuke Okada, Hiroko Mori, et al.
Internal Medicine (Tokyo, Japan)|May 2, 2017
Clinical Features of Patients with Basedow's Disease and High Serum IgG4 LevelsKeiichi Torimoto, Yosuke Okada, Akira Kurozumi, et al.
Endocrine Journal|August 6, 2025
Effectiveness of evocalcet for hypercalcemia in patients with primary hyperparathyroidismKenichi Tanaka, Yosuke Okada, Kenji Koikawa, et al.
Journal of UOEH|June 16, 2015
Prednisolone Dosing Regimen for Treatment of Subacute ThyroiditisTadashi Arao, Yosuke Okada, Keiichi Torimoto, et al.
Scientific Reports|October 7, 2022
Comprehensive immunophenotypic analysis reveals the pathological involvement of Th17 cells in Graves' diseaseKeiichi Torimoto, Yosuke Okada, Shingo Nakayamada, et al.
Journal of UOEH|March 12, 2013
Iatrogenic osteomalacia: report of two casesSunao Yamamoto, Yosuke Okada, Hiroko Mori, et al.
Neuro Endocrinology Letters|April 28, 2020
Response of thyrotropin-secreting pituitary tumors to preoperative lanreotide therapy. Report of two casesAkemi Tokutsu, Yosuke Okada, Keiichi Torimoto, et al.
Journal of UOEH|March 24, 2017
Comparison Between Effectiveness of 100 mg/day Sitagliptin and a Switch to Mitiglinide Calcium Hydrate/Voglibose from 50 mg/day Sitagliptin in Patients with Type 2 DiabetesTadashi Arao, Yosuke Okada, Keiichi Torimoto, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Diabetes, Obesity & Metabolism|May 11, 2019
Addition of canagliflozin to insulin improves glycaemic control and reduces insulin dose in patients with type 2 diabetes mellitus: A randomized controlled trialKeiichi Torimoto, Yosuke Okada, Yukiko Goshima, et al.
Scientific Reports|February 17, 2022
Hypoglycemia induces vascular endothelial dysfunction in subjects with normal glucose toleranceKenichi Tanaka, Yosuke Okada, Keiichi Torimoto, et al.
Internal Medicine (Tokyo, Japan)|October 13, 2017
The Effects of Mitiglinide and Repaglinide on Postprandial Hyperglycemia in Patients Undergoing Methylprednisolone Pulse TherapyKenichi Tanaka, Yosuke Okada, Hiroko Mori, et al.
Internal Medicine (Tokyo, Japan)|May 2, 2017
Clinical Features of Patients with Basedow's Disease and High Serum IgG4 LevelsKeiichi Torimoto, Yosuke Okada, Akira Kurozumi, et al.
Endocrine Journal|August 6, 2025
Effectiveness of evocalcet for hypercalcemia in patients with primary hyperparathyroidismKenichi Tanaka, Yosuke Okada, Kenji Koikawa, et al.
Journal of UOEH|June 16, 2015
Prednisolone Dosing Regimen for Treatment of Subacute ThyroiditisTadashi Arao, Yosuke Okada, Keiichi Torimoto, et al.
Scientific Reports|October 7, 2022
Comprehensive immunophenotypic analysis reveals the pathological involvement of Th17 cells in Graves' diseaseKeiichi Torimoto, Yosuke Okada, Shingo Nakayamada, et al.
Journal of UOEH|March 12, 2013
Iatrogenic osteomalacia: report of two casesSunao Yamamoto, Yosuke Okada, Hiroko Mori, et al.
Neuro Endocrinology Letters|April 28, 2020
Response of thyrotropin-secreting pituitary tumors to preoperative lanreotide therapy. Report of two casesAkemi Tokutsu, Yosuke Okada, Keiichi Torimoto, et al.
Journal of UOEH|March 24, 2017
Comparison Between Effectiveness of 100 mg/day Sitagliptin and a Switch to Mitiglinide Calcium Hydrate/Voglibose from 50 mg/day Sitagliptin in Patients with Type 2 DiabetesTadashi Arao, Yosuke Okada, Keiichi Torimoto, et al.
Pageof 8